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Posttranslational modifications of histones play
fundamental roles in many biological functions. Spe-
cifically, histone H4-K20 methylation is critical for
DNA synthesis and repair. However, little is known
about how these functions are regulated by the up-
stream stimuli. Here, we identify a tyrosine phosphor-
ylation site at Y72 of histone H4, which facilitates
recruitmentofhistonemethyltransferases (HMTases),
SET8 and SUV4-20H, to enhance its K20 methylation,
thereby promoting DNA synthesis and repair. Phos-
phorylation-defective histone H4 mutant is deficient
in K20 methylation, leading to reduced DNA synthe-
sis, delayed cell cycle progression, and decreased
DNA repair ability. Disrupting the interaction between
epidermal growth factor receptor (EGFR) and his-
tone H4 by Y72 peptide significantly reduced tumor
growth. Furthermore, EGFR expression clinically cor-
relates with histone H4-Y72 phosphorylation, H4-K20
monomethylation, and the Ki-67 proliferation marker.
These findings uncover a mechanism by which EGFR
transduces signal to chromatin to regulate DNA syn-
thesis and repair.
INTRODUCTION
Cells compact a large amount of DNA by wrapping it in a nucle-
osome composed of a histone octamer of two each of H2A, H2B,
H3, and H4. Posttranslational modifications (PTMs) of histones
such as acetylation, methylation, phosphorylation, ubiquitina-
tion, and ADP ribosylation play important roles in chromatin dy-
namics and functions (Munshi et al., 2009). A number of PTMs
of histone H4 have been identified, including acetylation at K5,
K8, K12, and K16, methylation at R3 and K20 in transcriptional224 Developmental Cell 30, 224–237, July 28, 2014 ª2014 Elsevier Inregulation, and phosphorylation at S1 during mitosis (Peterson
and Laniel, 2004). Lysine methylation on histone tails is function-
ally important in many biological events, such as transcriptional
regulation, heterochromatin formation, and DNA synthesis and
repair (Martin and Zhang, 2005). Of the five lysine residues in
the N-terminal tail of histone H4 (K5, K8, K12, K16, and K20),
K5 (Van Aller et al., 2012) and K20 (Pesavento et al., 2006) are
methylated. K5 methylation has just been recently identified
and is speculated to play a role in neoplastic process (Van Aller
et al., 2012). H4-K20 methylation plays a key role in multiple
functions, including DNA replication, mitosis, DNA repair, and
chromatin condensation (Yang and Mizzen, 2009). K20 can be
monomethylated by SET8 histone methytransferase (HMTase)
(Fang et al., 2002) and dimethylated by SUV4-20H HMTase
(Yang et al., 2008), which are responsible for DNA synthesis
(Huen et al., 2008; Jørgensen et al., 2007) and DNA repair
(Botuyan et al., 2006), respectively. Methylated lysine residues
of histones recruit proteins containing chromodomain, tudor
domain, or WD40-repeat domain in different biological pro-
cesses (Martin and Zhang, 2005). Among these protein motifs,
the tudor domain of 53BP1, a DNA damage checkpoint mediator
(Fang et al., 2002), interacts directly with dimethylated H4-K20 in
DNA repair processes (Botuyan et al., 2006). However, little is
known about how these important functions are regulated by up-
stream signaling when these HMTases are recruited to histone
H4 to methylate K20.
While the function of receptor tyrosine kinases (RTKs) as cell
surface proteins have been well characterized, recent evidence
indicates that RTKs, such as fibroblast growth factor receptor
1 (Reilly and Maher, 2001; Stachowiak et al., 1997), c-Met
(Gomes et al., 2008), vascular endothelial growth factor receptor
1 (Lee et al., 2007), and insulin-like growth factor 1 receptor
(IGF1-R) (Sehat et al., 2010), are also able to translocate to the
nucleus. In fact, 11 of 20 RTK subfamilies have been detected
in the nucleus (Wang et al., 2013;Wang andHung, 2012). In addi-
tion to the RTKs mentioned earlier, all of the epidermal growth
factor receptor (EGFR) family members are found in the nucleus
(Wang and Hung, 2009), with the functions of EGFR in thec.
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Y72 Phosphorylation Enhances K20 Methylationnucleus being the most extensively studied (Dittmann et al.,
2010; Han and Lo, 2012; Lo, 2010; Wang et al., 2013; Wang
and Hung, 2012).
Nuclear EGFR (nEGFR) is involved in several biological
functions, including DNA replication, DNA repair, transcriptional
regulation, and resistance to therapy, through associations with
various molecules (Chen et al., 2011; Huang et al., 2011; Huo
et al., 2010; Li et al., 2009; Wang and Hung, 2009; Wheeler
et al., 2010). Even though EGFR is known to recognize specific
promoter sequences of its target genes (Lin et al., 2001; Lo
et al., 2005), it does not actually have a DNA-binding domain.
Instead, our prior work demonstrated that EGFR interacts
with a DNA-binding protein, RNA helicase A, in the nucleus to
regulate transcription (Huo et al., 2010). It is interesting that
radiation has been shown to trigger EGFR translocation into
nucleus, which leads to activation of DNA-dependent protein
kinase (DNA-PK) in the DNA repair process (Dittmann et al.,
2005, 2008, 2010). More recently, nEGFR was shown to asso-
ciate with DNA-PK to phosphorylate PNPase at S776 and
inactivate its ribonuclease activity, which contributes to radio-
resistance of cancer cells (Yu et al., 2012). nEGFR also phos-
phorylates proliferating cell nuclear antigen at Y211 to maintain
its stability and, thus, controls its functions in DNA replication
and DNA repair (Wang et al., 2006). In addition, EGFR was
shown to associate with histone H3 in a study using proteomic
strategy to identify protein-protein interaction in the EGFR
signaling pathway (Blagoev et al., 2003). Although this study
did not reveal any specific functions of the EGFR/histone H3
interaction, it suggested possible interaction between nEGFR
and histone proteins. The identified nuclear functions of
EGFR and its potential interactions with the histone proteins
raised an interesting question of whether EGFR interacts with
core histones and regulates their functions.
In the current study, we demonstrate that EGFR interacts
with and phosphorylates histone H4 at Y72 (H4-Y72). Phos-
phorylated H4-Y72 then recruits SET8 and SUV4-20H through
interaction with their non-SET domains and enables these
HMTases to methylate H4-K20, thereby promoting DNA syn-
thesis and repair. Both epidermal growth factor (EGF) and
ionizing radiation (IR), which are known to enhance nuclear
localization of EGFR, can induce this mechanism. Our results
(1) provide mechanistic insights into how the tyrosine kinase
activity of EGFR in the nucleus regulates H4-K20 methylation
and affects DNA synthesis and repair and (2) open an avenue
toward the understanding of how K20 methylation-mediated
DNA synthesis and DNA repair may be regulated by upstream
signaling pathway.
RESULTS
EGFR Interacts with and Phosphorylates Histone H4
To investigate the relationship between core histones and
EGFR, we subjected EGFR-immunoprecipitated nuclear pro-
teins that correspond to the sizes of the core histones (bands
1–4; Figure S1A available online) from the nucleus to electro-
spray ionization tandem mass spectrometry (MS/MS) analysis,
and the results showed that the core histones, H2A, H2B, H3,
and H4, associated with EGFR. The EGFR/histones association
prompted us to perform an in vitro EGFR kinase assay to detectDevewhich histone is a potential substrate of EGFR. Histone H2B
and H4 were phosphorylated by EGFR, with the tyrosine
phosphorylation level of histone H4 being the strongest (Fig-
ure S1B). We then focused on EGFR/histone H4 and further
validated their interaction by reciprocal immunoprecipitation
in two different human cancer cell lines (Figure 1A). Their
interaction occurred in the nucleus but not in the cytosol (Fig-
ure S1C). On EGF stimulation, the interaction between EGFR
and histone H4 was enhanced, which was abolished by
AG1478, an EGFR tyrosine kinase inhibitor (TKI; Figure 1B).
We also observed similar phenomena under IR treatment (Fig-
ure 1C), indicating that the association between EGFR and
histone H4 is EGF- and IR-inducible and requires the tyrosine
kinase activity of EGFR. Isolation of Triton-resistant (chro-
matin-bound proteins) and Triton-extractable (chromatin-un-
bound proteins) fractions further suggested that the interaction
between EGFR and histone H4 occurs in the chromatin-en-
riched fraction (Figure S1D). Confocal microscopy also showed
that EGFR colocalized with histone H4 in the nucleus in both
MDA-MB-468 cells (Figure S1E, insets 2 and 4 versus 1 and
3) and A431 cells (Figure S1E, insets 6 and 8 versus 5 and 7;
see also three-dimensional image in Figure S1F). Quantitative
analysis indicated a 7- to 8-fold increase in EGF-stimulated
nuclear colocalization of EGFR and histone H4 (Figure S1G).
To visualize the in situ subcellular interaction between nEGFR
and histone H4, we performed a Duolink proximity ligation
assay, with results showing that both EGF and IR stimuli
induced EGFR and histone H4 interaction in the nucleus in vivo
(Figure 1D, red spots). Together, these results suggest that
EGF- or IR-enhanced EGFR and histone H4 association occurs
in the chromatin-enriched fraction.
To identify the specific domain of EGFR that associates with
histone H4, we used an in vitro transcription/translation method
to producemyc-tagged full-length (FL) EGFR and EGFR contain-
ing the extracellular domain (ECD) or the intracellular domain
(ICD), and we incubated them individually with recombinant
histone H4. The results showed that EGFR interacts with histone
H4 primarily through its ICD (Figure 1E), which was validated by
reciprocal immunoprecipitation from lysate of HEK293 cells
cotransfected with plasmids harboring the ICD of EGFR and
histone H4 (Figure 1F). The direct interaction between the ICD
of EGFR and histone H4 was validated by immunoprecipitation
of purified recombinant EGFR-ICD protein with pure histone
H4 protein (Figure S1H). Tyrosine phosphorylation of histone
H4 was significantly enhanced in the presence of EGF but abol-
ished by AG1478 in two cell lines (Figure 1G). Together, these
results indicate that tyrosine phosphorylation of histone H4 is
mediated by EGFR and that the ICD of EGFR interacts with
and phosphorylates histone H4.
EGFR Mediates Phosphorylation at Y72 of Histone H4
To identify the tyrosine phosphorylation site of histone H4
in vivo, immunoprecipitated histone H4 from the nucleus of
A431 cells was subjected to MS/MS analysis (Figure 2A). We
reproducibly identified specific peptides containing phosphory-
lated tyrosine residue of H4-Y72, indicating that this specific
phosphorylation event occurs under physiological conditions.
Sequence alignment of this region showed that this tyrosine res-
idue is conserved across different species from Drosophila tolopmental Cell 30, 224–237, July 28, 2014 ª2014 Elsevier Inc. 225
Figure 1. Histone H4 Interacts with EGFR
(A) Histone H4 and EGFR reciprocal immunoprecipitation (IP), followed by immunoblotting (IB) with the indicated antibody.
(B) Histone H4 IP/IB of serum-starved MDA-MB-468 cells treated with or without EGF and/or AG1478 for 30 min.
(C) Histone H4 IP/IB of serum-starved MDA-MB-468 cells treated with or without IR and/or AG1478 for 30 min.
(D) The in situ subcellular interaction between EGFR and histone H4 determined by Duolink proximity ligation assay in serum-starved MDA-MB-468 cells treated
with or without EGF (20 ng/ml) or postirradiation (20 Gy) for 30 min (arrows indicate red spots). Blue indicates DAPI-stained nucleus.
(E) The in vitro translated myc-tagged FL-, ECD-, or ICD-EGFR (top) was individually incubated with purified recombinant histone H4 protein (middle) and
immunoblotted to determine their interactions (bottom).
(F) HEK293 cells were cotransfected with HA-histone H4 plasmid with myc-ECD-EGFR or myc-ICD-EGFR plasmid for 24 hr. Cell lysate was examined by
reciprocal IP/IB with antibodies against myc and HA, respectively.
(G) Phosphotyrosine (p-Y) of histone H4 was examined by IP/IB with anti-p-Y or anti-histone H4 antibody, respectively, in 24-hr serum-starved cells treated with
or without EGF and/or AG1478 for 30 min.
See also Figure S1.
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Y72 Phosphorylation Enhances K20 Methylationhuman (Figure 2A, inset), implying that H4-Y72 phosphorylation
may be an evolutionarily conserved event and is likely associated
with important functions. We further performed an in vitro kinase
assay with purified recombinant histone H4 protein (His-H4Y72 or
His-H4Y72F) and glutathione S-transferase (GST)-EGFR kinase
domain to demonstrate that EGFR directly phosphorylates his-
tone H4 at Y72 but not the Y72F mutant (Figure S1I).
To investigate H4-Y72 phosphorylation in vivo, we generated
an antibody against Y72-phosphorylated histone H4 (H4-pY72)
and characterized its specificity. The H4-p-Y72 antibody recog-
nized only the phospho- (p-Y72) but not the nonphospho- (NP)
histone H4 peptide or other H4 phospho-peptides such as
p-Y51 and p-Y88/p-Y98 (Figure S2A). The antibody immuno-
precipitated only the wild-type (WT) hemagglutinin (HA)-H4
but not the HA-Y72F mutant in the lysate from each stable
transfectant (Figure S2B, right panel), and the signals were226 Developmental Cell 30, 224–237, July 28, 2014 ª2014 Elsevier Indiminished by pretreatment of phosphatase (Figure S2C).
Immunoprecipitation using our anti-histone H4-pY72 was effi-
cient, as there was only a trace amount of tyrosine-phosphor-
ylated H4 left in the unbound fractions (Figure S2D). We further
performed immunoprecipitation using the antibody with dena-
tured or native cell lysate and found that the anti-histone H4-
pY72 antibody interacted mainly with histone H4 from native
cell lysate (Figure S2E). We observed positive signals in EGF-
or IR-treated cells but not in the EGFR knockdown cells from
immunofluorescence staining using the anti-histone H4-pY72
antibody (Figure S2F). Taken together, these results indicate
that the antibody recognizes primarily the native form of p-
Y72 on histone H4. Using the H4-pY72 antibody, we showed
that EGFR stimulated the H4-Y72 phosphorylation, which
was inhibited by AG1478 in vivo in three different cell lines
(Figure 2B). Expression of EGFR also enhanced the level ofc.
Figure 2. EGFR Mediates Tyrosine Phosphorylation of H4-Y72
(A) MS/MS analysis of A431 nuclear extract immunoprecipitated with anti-histone H4 antibody. Top: the flanking regions of histone H4-Y72 among different
species. Dotted circles indicate phosphotyrosine-containing peptide fragments.
(B) Cells were serum starved for 24 hr and then treated with or without EGF and/or AG1478 for 30 min. Top: the level of histone H4-pY72 determined by IP/IB.
Bottom: the endogenous levels of indicated proteins examined by IB.
(C) HEK293 cells were cotransfected WT or Y72F mutant (Y72F) histone H4 plasmid with or without myc-EGFR plasmid and/or AG1478 or gefitinib for 24 hr.
Exogenous histone H4-Y72 phosphorylation was detected by IP/IB.
(D) MDA-MB-468 cells were infected with lentivirus containing shRNAs against luciferase (Luc) or EGFR (EGFR-1 or EGFR-2). Phosphorylated histone H4 at Y72
of each transfectant was examined.
See also Figure S2.
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histone H4, but not the Y72F mutant, and this phosphorylation
can be abrogated by AG1478 or gefitinib, a clinically used TKI
(Figure 2C). Consistently, knockdown of EGFR by two different
short hairpin RNAs (shRNAs) also significantly reduced the
H4-Y72 phosphorylation (Figure 2D). Unlike EGF-stimulated
kinases such as EGFR, in which phosphorylation peaked at
1 hr and then decreased at 4 hr, EGF-stimulated phosphoryla-
tion at histone H4-Y72 was more stable and sustained for at
least 4 hr (Figure S2H). Collectively, these results demonstrate
that EGFR is a tyrosine kinase for Y72 of histone H4 in vivo.
Y72 Phosphorylation Enhances Histone H4 Methylation
at K20
To determine whether EGFR-mediated H4-Y72 phosphorylation
might regulate other PTMs and modulate their physiological
functions, we examined the effect of H4-Y72 phosphorylation
on three well-known PTMs of histone H4 (methylation at K20
and acetylation at K5 and K8 of the histone H4 tail). The expres-
sion of EGFR significantly increased K20 methylation of WT his-Devetone H4 but not of the Y72Fmutant (Figure S3A), suggesting that
EGFR-mediated methylation is associated with H4-Y72 phos-
phorylation. We noticed that the level of H4-K5 acetylation was
also increased in the presence of EGFR, regardless of the H4-
Y72 phosphorylation status, but neither EGFR nor H4-Y72 phos-
phorylation status affected H4-K8 acetylation (Figure S3A).
These findings suggest that H4-Y72 phosphorylation is involved
in regulation of H4-K20 methylation but is not associated with
H4-K5 or -K8 acetylation.
H4-K20 can bemono- and dimethylated to regulate DNA repli-
cation (Huen et al., 2008; Jørgensen et al., 2007) and DNA repair
(Botuyan et al., 2006), respectively. Thus, we further asked
how H4-Y72 phosphorylation affects H4-K20 methylation and
its associated biological consequences. The levels of both
H4-K20 mono- and dimethylation were increased under EGF
stimulation but reduced by AG1478 or gefitinib treatment in
MDA-MB-468 cells (Figure 3A). Inhibition of H4-K20 methylation
by AG1478 was also evident in another cell line (Figure S3B). As
shown in Figure S2I, about 35% of histone H4 was phosphory-
lated at Y72 on EGF stimulation. The amount of histone H4 leftlopmental Cell 30, 224–237, July 28, 2014 ª2014 Elsevier Inc. 227
Figure 3. Phosphorylation at Y72 of Histone H4 Enhances Its Methylation at K20
(A) The expressions of indicated proteins from 4-day serum-starved MDA-MB-468 cells treated with or without EGF and/or AG1478 or gefitinib for 30 min.
(B) HEK293 cells were cotransfected with HA-histone H4 or -H4Y72F plasmid with or without myc-EGFR plasmid and/or AG1478. The exogenous HA-histone H4
or HA-H4Y72F was immunoprecipitated with anti-HA antibody, followed by IB with specific antibodies against methylated histone H4 at K20.
(C) HEK293 cells were cotransfected with HA-tagged histone H4 plasmid with or without DNLS- or WT-EGFR plasmid. Nuclear and cytosolic fractions of the
indicated proteins are shown at bottom.
(D) SET8 or SUV4-20H HMTase was immunoprecipitated from the nuclear extract of MDA-MB-468 cells with specific antibody. An increasing amount of
immunoprecipitated SET8 or SUV4-20H nuclear extract (50, 100, or 200 mg) was incubated with recombinant histone H4 or H4-Y72F protein in the HMTase
reaction buffer. Histone H4 K20 methylation and input were detected by IB.
(E) The recombinant WT and Y72F mutant histone H4 proteins were treated with or without EGFR kinase, followed by HMTase assay with immunoprecipitated
SET8 or SUV4-20H from nuclear extract (50 mg). The histone H4-K20me1, H4-K20me2, and input of the histone were also examined.
(F) The same sequential in vitro EGFR kinase and HMTase assay as in (E) was performed with or without EGF and/or AG1478.
See also Figure S3.
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92%, 47%, and 89% of total input histone H4 in control cells,
EGF-stimulated cells, and EGF plus AG1478-treated cells,
respectively. Around 30 to 40% of total K20-methylated H4
was not phosphorylated at Y72 in the unbound fraction. Simi-
larly, cotransfection of EGFR and WT histone H4 also enhanced
the levels of H4-K20 methylations in human embryonic kidney
293 (HEK293) cells, but these levels were suppressed by
AG1478. However, only a trace amount of H4-K20 methylation
of H4-Y72F was detected by cotransfection of EGFR and the
HA-Y72F mutant (Figure 3B), suggesting that EGFR-increased
K20 methylation is mediated through EGFR-histone H4-Y72
phosphorylation.
To ensure that the Y72F mutant still retains its functions to
associate with chromatin and other histone core proteins, we
established MDA-MB-468 stable transfectants expressing HA-
taggedWT or Y72Fmutant histone H4 (HA-H4). The stable trans-
fectants expressed equal amounts of exogenous HA-H4 (Fig-
ure S3C). The Y72F mutant did not affect its binding ability to228 Developmental Cell 30, 224–237, July 28, 2014 ª2014 Elsevier Inchromatin, as is evident from similar levels of HA-H4 WT and
Y72F mutant in the Triton-resistant chromatin bound fraction
(Figure S3D); it also did not alter its interaction with other core
histones in the chromatin (H3, H2A, and H2B; Figure S3E).
Both EGF- and IR-stimulated histone H4-Y72 phosphorylation
and subsequent K20 methylation in H4-Y72F stable transfectant
were less than that in mock- or WT H4 transfectant (Figures S3F
and S3G).
We expressed an EGFR mutant lacking the nuclear localiza-
tion sequence (NLS), which is defective in nuclear translocation
but still retains its kinase activity (Hsu and Hung, 2007; Hsu
et al., 2009). This mutant could not be detected in the
nuclear fraction, consistent with the previous reports (DNLS;
Figure 3C) and hence was unable to increase H4-Y72 phosphor-
ylation and H4-K20 methylation (Figure 3C, top), indicating
that H4-Y72 phosphorylation-mediated H4-K20 methylation
indeed depends on the presence of EGFR in the nucleus.
Together, the results suggest that nEGFR-mediated Y72 phos-
phorylation of histone H4 enhances both its monomethylationc.
Figure 4. Phosphorylation at Y72 of Histone H4 Enhances Its Interaction with SET8 and SUV4-20H
(A) Serum-starved MDA-MB-468 cells were treated with or without 20 ng/ml EGF and/or AG1478 (10 mM) for 30 min. Triton-resistant extract was isolated and
immunoprecipitated with anti-histone H4 antibody to determine its association with SET8, SUV4-20H, or SUV39H1 HMTases by IB.
(B) Histone H4 in nuclear fractions from indicated stable transfectants with or without AG1478 (10 mM) was immunoprecipitated to determine its association with
SET8 or SUV4-20H (top). Endogenous levels of indicated proteins in the nuclear fraction are indicated at the bottom.
(C) Purified GST-SET8 and -SUV4-20H2 proteins were stained with Coomassie blue (top) or immunoblotted with specific antibodies (bottom).
(D) Different amounts of histone H4-Y72 peptides (IRDAVT-Y-TEHAKR) containing NP or phospho-residue at Y72 (p-Y72) were dotted on to the polyvinylidend
fluoridemembrane, stained with Ponceau S solution (bottom), and then incubated with purified GST-SET8 or GST-SUV4-20H2 protein. Binding of SET8 or SUV4-
20H to the coated H4 peptides was determined by IB (top).
(E) Histone H4-pY72 peptide was dotted on to membrane and incubated with GST-SET8 or GST-SUV4-20H2 protein with or without H4-Y72 peptide (NP or p-
Y72), followed by IB.
(F) Histone H4-pY72 peptide was conjugated on agarose beads and then applied to pull down against GST-SET8, GST-SUV4-20H2, and GST-SUV39H1 re-
combinant proteins.
(G) HEK293 cells were transfected with FL, S, or NS regions of SET8 or SUV4-20H2 for 24 hr. Expression of each fragment was examined by IB against V5.
(H) Cell lysate from each transfectant was incubated with the H4-pY72 peptide-coated membrane, followed by IB against V5.
See also Figure S4.
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Y72 Phosphorylation Enhances K20 Methylationand dimethylation at K20 but does not affect its ability to asso-
ciate with other histone core proteins or its binding to chromatin.
Next, we asked whether Y72 phosphorylation of histone H4
affects its methylation by SET8 and SUV4-20H in vitro. Using
an in vitro HMTase activity assay, we showed that the WT his-
tone H4, but not the Y72F mutant, was mono- and dimethylated
at K20 by immunoprecipitated SET8 and SUV4-20H, respec-
tively, in a dose-dependent manner (Figure 3D). To further
establish the enhancement of H4-K20 methylation by H4-Y72
phosphorylation, we performed sequential in vitro EGFR kinase
and HMTase activity assays (Figure 3E), which showed that
H4-K20 methylation was enhanced by pretreating histone H4
with EGFR kinase (Figure 3E, lane 4 versus 3) whereas AG1478
diminished the in vitro EGFR kinase-enhanced HMTase activity
toward H4-K20 mono- and dimethylation (Figure 3F). However,
pretreatment of EGFR kinase had no effect on the H4-Y72F
mutant (Figure 3E, lane 8 versus 7). Thus, the results supportDevethat EGFR-mediated H4-Y72 phosphorylation enhances histone
H4 to serve as a substrate for SET8 and SUV4-20H HMTases.
Y72 Phosphorylation of Histone H4 Enhances
Recruitment of SET8 and SUV4-20H
Next, we asked whether H4-Y72 phosphorylation affects its
interactions with SET8 and SUV4-20H. Under EGF stimulation,
the association between histone H4 and SUV4-20H or SET8
was significantly increased but abolished by AG1478 (Figure 4A;
Figure S4A). However, SUV39H, a H3-K9 methylase, did not
interact with histone H4, even after EGFR stimulation (Figure 4A).
In addition, WT histone H4, but not Y72F mutant, associated
with SUV4-20H and SET8 (Figure 4B), suggesting that Y72 phos-
phorylation of histone H4 may be critical for it to recruit SET and
SUV4-20H. To further address whether SUV4-20H and SET8
specifically recognize the phospho-Y72 residue, we used 13-
amino-acid peptides derived from histone H4 that contain eitherlopmental Cell 30, 224–237, July 28, 2014 ª2014 Elsevier Inc. 229
Figure 5. Histone H4-Y72 Phosphorylation Is Involved in DNA Synthesis
(A) Stable transfectants were serum starved for 24 hr, and then they were treated with or without EGF and/or AG1478 and pulse-labeled with 100 mM BrdU for
12 hr. Histone H4-associated newly synthesized DNA was determined. Top right: expression of HA-histone H4 in each stable transfectant.
(B) Stable transfectants were pulse-labeled with 100 mM BrdU for 4 hr. Subsequently, the DNA contents and the incorporated BrdU in each transfectant were
determined by flow cytometry. The percentage of cells distributed in each phase of cell cycle is shown.
(C) Stable transfectants were treated with nocodazole and/or AG1478 for 24 hr. The distributions of cells in G1, S, and G2/M phases of cell cycle were analyzed by
flow cytometer (Figure S5A). The bar plot is the G1 (%) in each treatment.
(legend continued on next page)
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Y72 Phosphorylation Enhances K20 Methylationp-Y72orNP-Y72 in thecenter of thepeptides asbait todetermine
the interaction between Y72 of histone H4 and SUV4-20H and
SET8. As evident from the dot blot analysis, both SET8 and
SUV4-20H from cell lysates interacted only with the p-Y72
peptide (Figure S4B). In addition, these two purified HMTases
(Figure4C)also recognized thep-Y72but not theNPpeptide (Fig-
ure 4D), and their interactions can be disrupted by the pY72 but
not the NP peptide in a competition assay (Figure 4E). The pull-
down assay using the pY72 peptide recognized only GST-SET8
and GST-SUV4-20H2, but not GST-SUV39H1 (Figure 4F). To
determine which region of these two HMTases interacts with
p-Y72 peptide, we first constructed SET8 and SUV4-20H with
or without the SET domain that contains the K20 HMTase
active site. We then transfected the FL domain, SET-containing
(S) domain, or non-SET-containing (NS) domain of these two
HMTases into HEK293 cells (Figure 4G). The results showed
that the p-Y72 peptide mainly associated with the NS region of
SET8 and SUV4-20H2 (Figure 4H), indicating that the NS region,
which does not have awell-defined function, interactswith p-Y72
of histoneH4. The results suggest that EGF/EGFR-mediated Y72
phosphorylation of histone H4 enhances its interaction with the
SET8 and SUV4-20Hmethyltransferases through the NS domain
to bring the SET domain closer to K20 for methylation.
H4-Y72 Phosphorylation Promotes DNA Synthesis
SET8 is known to monomethylate H4-K20 during DNA synthesis
and is required for DNA replication (Huen et al., 2008). Thus, to
determinewhether H4-Y72 phosphorylation affects DNA synthe-
sis, cells were pulse-labeled with bromodeoxyuridine (BrdU),
and the newly synthesized DNA associated with histone H4
(WT or Y72F mutant) was detected by chromatin immunoprecip-
itation to measure the relative amount of immunoprecipitated
BrdU-labeled DNA. As shown in Figure 5A, EGF treatment
increased the amount of newly synthesized DNA in WT histone
H4, but not in mutant Y72F or K20R. Addition of AG1478 atten-
uated EGF-stimulated DNA synthesis in the WT histone H4. It
should be mentioned that the K20R mutant behaved similarly
to the Y72F mutant, having lower ability of DNA synthesis, and
this is in line with the impairment of K20 methylation in the
Y72F mutant. These results support the hypothesis that H4-
Y72 phosphorylation promotes DNA synthesis.
To assess the speed of DNA synthesis, cells were pulse-
labeled with BrdU and analyzed by flow cytometry according
to a previous report (Jørgensen et al., 2007). In BrdU incorpora-
tion experiments, the BrdU signal from nonlabeled cells was
used as a cutoff line. Cells in the S phase distributed above the
line were in replicating S phase and labeled as S (R); cells distrib-
uted below the linewere in nonreplicating S phase and labeled as
S (NR). Remarkably, 30%–40% of mock and WT histone H4 sta-
ble transfectants were in the replicating S phase, whereas only
around 10% of the H4-Y72F and H4-K20R transfectants were
in the replicating S phase. Consistent with the lower percentage
of cells in the replicating S phase, we observed a higher percent-
age (around 10%) of H4-Y72F and H4K20R stable transfectants(D) Stable transfectants were synchronized at G1 phase and then released to norm
stage of cell cycle were analyzed by flow cytometry (Figure S5B). Bar graph sho
(E) Relative number of cells of each stable transfectant was determined at indica
See also Figure S5.
Devein the nonreplicating S phase than in the mock and WT histone
H4 transfectants (around 5%) (Figure 5B). Together, these re-
sults suggest that DNA synthesis is slower in the H4-Y72F
mutant, delaying the replicating S phase as a result of defective
K20 methylation.
In support of this notion, we measured the effect of phos-
phorylated H4-Y72 on cell cycle progression using a previously
established protocol (Jørgensen et al., 2007). Stable transfec-
tants expressing WT or Y72F mutant histone H4 were treated
with a mitotic spindle inhibitor, nocodazole, to inhibit mitosis
and prevent cells from progressing to the next G1 phase. Under
this condition, if the cell cycle progresses faster, more cells will
transition from G1 to S and stop at the G2/M phase; therefore,
the number of cells in the G1 phase will be reduced, and vice
versa. Treatment of the histone H4-Y72F transfectant with no-
codazole resulted in 20% of cells in the G1 phase, compared
with 6% to 9% of cells in the G1 phase for the mock and
WT transfectants, indicating that Y72F mutant reduced cell cy-
cle progression (Figures 5C and S5A). In contrast, treatment
with AG1478 abolished the differences we observed between
the mock, WT H4, and Y72F transfectants, with all three having
about 18% to 20% of cells in the G1 phase (Figures 5C and
S5A). Cells were synchronized at G1 phase by double thymi-
dine block and released to normal culture medium for different
time intervals to progress cell cycle. As shown in Figures 5D
and S5B, the decrease in G1 phase and increase in S phase
in mock and WT H4 transfectants were more than that in H4-
Y72F transfectants, particularly at the at the 4 hr time point,
indicating that H4-Y72F transfectants entered S phase more
slowly than mock or WT transfectants. Moreover, EGF stimu-
lated histone H4-Y72 phosphorylation, K20 methylation (Fig-
ure S5C), and DNA synthesis (Figure S5D) in a dose-dependent
manner. Finally, cell proliferation assay revealed that H4-Y72F
transfectant grew slower than mock or WT H4 transfectant.
Regression analysis of the growth curve of each transfectant
indicated that cell doubling time was 26, 26, and 31 hr in
mock, WT H4, and H4-Y72F mutant transfectants, respectively
(Figure 5E). Collectively, these results suggest that the Y72F
mutant impairs DNA synthesis and delays S phase progression
and cell growth as a result of defective K20 methylation.
H4-Y72 Phosphorylation Regulates DNA Double-
Stranded Break Repair in Response to IR
Dimethylation at K20 of histone H4 is involved in DNA double-
stranded break (DSB) repair (Botuyan et al., 2006; Sanders
et al., 2004). To determine whether H4-Y72 phosphorylation
affects this function, we determined the recovery of IR-induced
DNA damage by observing the level of phospho-histone H2AX
at S139 (g-H2AX), which is indicative of IR-induced DNA
damage. At 1 hr after irradiation, g-H2AX was induced, and
within 8 hr of recovery, the increased level of g-H2AX was
gradually reduced to the basal level in WT histone H4 cells; how-
ever, the reduction rate of g-H2AX was slower in the Y72F
mutant (Figure 6A). Consistently, the intensity of g-H2AX inal culture medium for indicated time intervals. The distributions of cells in each
ws quantitative results.
ted time intervals. Error bars, mean ± SD.
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Figure 6. Histone H4-Y72 Phosphorylation Is Involved in DNA DSB Repair
(A) Top: each stable transfectant was irradiated with 20 Gy and incubated at 37C to recover for the indicated time. Expression of g-H2AX was examined by IB.
Bottom: relative quantity of g-H2AX was normalized to H2AX 1 hr after irradiation.
(B) The quantitation of g-H2AX in Figure S6A.
(C) HEK293 cells were cotransfected with circular (cir-pGL3) or linearized (lin-pGL3) luciferase plasmid with myc-EGFR and increased amounts of WT or Y72F
mutant histone H4 plasmid for 48 hr with or without AG1478. The relative end-joining efficiency was determined by the percentage of luciferase activity from cells
with lin-pGL3 over that with cir-pGL3. Error bars, mean ± SD. Bottom: the expression of transfected plasmids as indicated.
(D) A similar experiment as described in (C) was also performed using another histone H4 K20R mutant plasmid (800 ng) with or without EGFR and/or AG1478.
(E) Serum-starvedMDA-MB-468 cells were treatedwith or without irradiation and/or AG1478. After 1 hr, Triton-resistant fraction was immunoprecipitated against
histone H4-p-Y72, followed by IB with the indicated antibodies. Right: endogenous level of indicated proteins.
(F) A proposed model of nEGFR-mediated H4-Y72 phosphorylation in the regulation of H4-K20 methylation.
See also Figure S6.
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Y72 Phosphorylation Enhances K20 Methylationimmunofluorescence staining, which peaked at 1 hr after irradi-
ation, was reduced by 50% in cells expressing WT histone H4
but only by 20% in those expressing the Y72F mutant within a
2 hr recovery period (Figures 6B and S6A), suggesting that the
Y72F mutant reduced its DNA repair activity.232 Developmental Cell 30, 224–237, July 28, 2014 ª2014 Elsevier InTo further validate that H4-Y72 phosphorylation affects DNA
repair, we examined the end-joining capacity by transfecting
HEK293 cells with linearized luciferase plasmid, which is inac-
tive unless it is recircularized by end-joining DNA repair. In
the presence of WT histone H4, luciferase activity remainedc.
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Y72 Phosphorylation Enhances K20 Methylationthe same, whereas expression of the Y72F mutant significantly
reduced luciferase activity in a dose-dependent manner (up to
40% of inhibition; Figure 6C), indicating that the mutant
impaired end-joining activity. AG1478 also decreased end-
joining activity in cells expressing WT histone H4 but had no
effect on the Y72F mutant. Consistently, overexpression of
EGFR significantly increased end-joining ability in cells with
WT histone H4, which was reduced by AG1478. However,
EGFR expression had no effect on the histone H4 Y72F or
K20R mutant (Figure 6D), suggesting that EGFR-enhanced
end-joining activity is modulated by Y72 phosphorylation and
K20 methylation.
Dimethylated H4-K20 participates in DNA repair by recruiting
53BP1 to the damaged site (Botuyan et al., 2006), and IR
enhances nuclear translocation of EGFR in the activation of
DNA repair (Dittmann et al., 2005, 2008, 2010). To determine
whether H4-Y72 phosphorylation, which enhances H4-K20
methylation, also affects the recruitment of 53BP1 in DNA repair,
we analyzed H4-Y72 phosphorylation after IR and examined its
interaction with 53BP1. After IR, H4-Y72 phosphorylation was
increased in the chromatin-enriched Triton-resistant fraction
but reduced in the presence AG1478 (Figure 6E). Coimmunopre-
cipitation also showed that H4-Y72 phosphorylation increased
H4-K20 methylation (me1/me2) to recruit SET8 and SUV4-20H
and subsequently enhanced the levels of 53BP1 in the chro-
matin-enriched Triton-resistant fraction on IR (Figure 6E). A
dose-dependent response to IR was observed for histone H4-
Y72 phosphorylation, K20 methylation, and association of
53BP1 in DNA repair (Figure S6B).
The functional link between nEGFR and IR-induced DNA
repair has been reported in which EGFR-induced phosphatidyli-
nositol 3-kinase (PI3K)/AKT activation and subsequent activa-
tion of DNA-PK regulates radiosensitivity (Qu et al., 2013;
Toulany et al., 2006). We further tested whether PI3K/AKT is
involved in EGFR-mediated histone H4-Y72 phosphorylation
on IR. To this end, we examined the effects of PI3K/AKT inhibi-
tors on histone H4-Y72 phosphorylation and K20 methylation
in IR-induced DNA repair. As shown in Figure S6C, addition of
PI3K/AKT inhibitors (LY294002, API2, and AKT inhibitor X) did
not affect the IR-stimulated histone H4-Y72 phosphorylation
and K20 methylation, suggesting that EGFR-induced histone
H4-Y72 phosphorylation and K20 methylation are not mediated
by activation of PI3K/AKT pathway. All together, these results
suggest that IR increased the levels of nEGFR for H4-Y72 phos-
phorylation to recruit SET8 and SUV4-20H for H4-K20 methyl-
ation and subsequent binding by 53BP1 for DNA repair. These
findings provide a plausible mechanism linking the two well-
known DNA replication and DNA repair events—namely, EGFR
and histone H4-K20—and should open a new avenue toward
the understanding of how growth factor receptors may regulate
these two events through the histone H4-Y72 phosphorylation/
K20 methylation cascade.
In summary, we report a link between nEGFR and histone
H4 function. As depicted in Figure 6F, nEGFR first phos-
phorylates histone H4-Y72 (1). Then, the non-SET domain
of SET8 and SUV4-20H binds to p-Y72 (2) and brings the
SET domain in close proximity to K20 for methylation (3).
Methylation at K20 leads to increased DNA synthesis and
DNA repair.DeveDisruption of the Interaction between EGFR and Histone
H4 by Y72 Peptide Demonstrates Tumor-Suppressive
Activity In Vivo
To determine whether disruption of the EGFR-histone H4 bind-
ing interface affects tumor growth, we first evaluated the effect
of several tyrosine peptides on the EGFR-histone H4 interaction
and found that the Y72 peptide more potently disrupted their
interaction than other phosphotyrosine peptides (Figure S7A)
or scrambled control (Figure 7A). We then tested the antitumor
effect of Y72 peptide in an MDA-MB-468 breast cancer xeno-
graft tumor model. Mice treated with Y72 peptide had signifi-
cantly reduced tumor size (Figures 7B and S7B) and weight
(Figure 7C), compared with those treated with PBS or scrambled
peptide. The levels of histone H4-pY72 were also reduced in the
tumor mass from mice treated with the Y72 peptide (Figure 7D).
Together, these results further validate a biologically important
role of EGFR-mediated histone H4-Y72 phosphorylation and
demonstrate that blocking the EGFR-histone H4 interaction
has therapeutic potential.
EGFR Expression Correlates with Histone H4-Y72
Phosphorylation and K20 Methylation in Human
Tumor Samples
To determine the clinical relevance of this pathway, we exam-
ined the levels of EGFR, histone H4-pY72, histone H4-K20me1,
and Ki-67 in human breast tumor samples using immunohisto-
chemical (IHC) staining. We first verified the specificity of our
anti-histone H4-pY72 antibody for IHC staining by peptide
competition. The IHC staining of histone H4-pY72 was reduced
only by phospho-histone H4-pY72 peptide but not NP-histone
H4-Y72 and phospho-histone H4-pY51 peptide (Figure S2G),
indicating that our anti-histone H4-pY72 antibody is specific
to phosphorylated Y72 of histone H4. Multiple-variable analysis
of the results from IHC staining revealed that EGFR expression
was significantly correlated with H4-pY72 (p = 0.049),
H4-K20me1 (p = 0.011), and proliferation marker Ki-67 (p =
0.002) (Figure 7E; see also Figure S7C for representative im-
ages of IHC staining). In addition, the level of H4-K20me1
was higher in cells expressing nuclear EGFR than in cells
with cytosolic EGFR (p = 0.0598). However, there was no
detectable difference in H4-K20me1 between the cells with
cytosolic EGFR and without EGFR (p = 0.5329) (Figure 7F), sug-
gesting the potential role of nuclear EGFR in regulation of his-
tone H4-K20 methylation in breast cancer. Taken together,
these findings provide a significant clinical relevance between
EGFR, histone H4-Y72 phosphorylation, and K20 methylation
in human breast cancer.
DISCUSSION
Aside from their prominent role in cell surface signal transduc-
tion, EGFR family members also have noncanonical functions,
such as transcriptional regulation, DNA synthesis, and DNA
repair in the nucleus (Dittmann et al., 2008). However, themolec-
ular mechanisms underlying these nuclear functions are not
completely understood. The present study identifies a mecha-
nism by which nEGFR regulates DNA synthesis and repair. We
showed that nEGFR phosphorylates histone H4-Y72, which fa-
cilitates the recruitment of SET8 and SUV4-20H HMTases forlopmental Cell 30, 224–237, July 28, 2014 ª2014 Elsevier Inc. 233
Figure 7. Y72 Peptide Demonstrates Tumor-Suppressive Activity In Vivo, and Histone H4-pY72 and K20me1 Correlate with EGFR Expression
in Clinical Samples of Human Breast Cancer
(A) MDA-MB-468 cell lysates were subjected to IP with anti-EGFR antibody in the presence or absence of Y72 or scrambled peptide (200 mM), followed by IB
against histone H4 and EGFR.
(B) The tumor volume of mice treated with PBS or the indicated peptides. Error bars, mean ± SD.
(C) Bar graph shows the quantative tumor weight in each group. Error bars, mean ± SD.
(D) Protein lysates from tumors in (C) were subjected to western blot analysis with the indicated antibodies. To detect histone H4-pY72, lysates were subjected to
IP first with anti-histone H4-pY72 antibody, followed by IB with anti-histone H4 antibody.
(E) Correlations between expression of EGFR and histone H4-pY72, histone H4-K20me1, or Ki-67 in surgical specimens of breast cancer were analyzed by
Pearson chi-square test. M = membrane, N = nucleus, and C = cytoplasm.
(F) IHC staining of human breast tumor tissue sections for EGFR and histone H4-K20me1. The plot represents the quantitative results of histone H4-K20me1 in the
tissue sections with different EGFR status. EGFR N+, nuclear EGFR positive; EGFR C+, cytosolic EGFR positive; EGFR, EGFR negative. Error bars, mean ± SD.
See also Figure S7.
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Y72 Phosphorylation Enhances K20 MethylationH4-K20 mono- and dimethylation to regulate DNA synthesis and
DNA repair (Figure 6F).
It is commonly known that catalytically inactive enzymes
associate with their substrates more avidly when they are un-
able to modify their substrates. While this is generally true for
enzyme-substrate interactions, there are many exceptions
when substrates are proteins. For example, the interaction of
Grb10 with insulin receptor and IGF1-R depends on the recep-
tor’s tyrosine kinase activity. Mutation of the tyrosine residues
by Y1150F and Y1151F within the insulin receptor’s activation
loop dramatically reduced the interaction (He et al., 1998). Acti-
vation of focal adhesion kinase by Y397 phosphorylation is also
required for its association with phosphatidylinositol 3-kinase
(Chen et al., 1996). In addition, the binding of ATR to fragile234 Developmental Cell 30, 224–237, July 28, 2014 ª2014 Elsevier InDNAs also requires its kinase activity (Wang et al., 2010b). Simi-
larly, we found that EGF- or IR-induced association of EGFR
and histone H4 requires the tyrosine kinase activity of EGFR
(Figures 1B and 1C).
Methylation at histone H4-K20 is a sequential and dynamic
process during cell cycle progression or DNA repair. In general,
SET8-mediated histone H4-K20monomethylation is required for
G1/S transition and S phase (Huen et al., 2008; Jørgensen et al.,
2007); SUV4-20H-mediated histone H4-K20 dimethylation is
involved in the recruitment of 53BP1 for DNA repair (Botuyan
et al., 2006). However, it has been reported that SUV4-20H-
mediated di- and/or trimethylation of histone H4-K20 also play
important roles for recruitment of the origin recognition complex
to the replication origins (Beck et al., 2012); de novo histonec.
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recruitment in DNA repair (Oda et al., 2010). Thus, SET8 and
SUV4-20H may dynamically interact with histone H4 in both
DNA replication and DNA repair.
The Src homology 2 (SH2) and phosphotyrosine-binding (PTB)
domains are important tyrosine kinase signaling domains that
recognize phosphotyrosine-containing binding sites (Schles-
singer and Lemmon, 2003). Although we could not predict a
distinct SH2 or PTB domain on the non-SET regions of SET8
and SUV4-20H, sequence alignment of these two non-SET
regions of SET8 and SUV4-20H revealed seven consensus argi-
nine residues (Figure S4C). Arginine residues on SH2 domain are
known to have particularly prominent roles as key contacts with
the phosphotyrosines (Yaffe, 2002), suggesting that these
consensus arginine residues on the non-SET regions of SET8
and SUV4-20H may be key residues for PTB. Further study
would be required to demonstrate this.
There is recent evidence showing that tyrosine phosphoryla-
tion of histones affects their functions. WSTF, a transcription
factor, has intrinsic tyrosine kinase activity toward Y142 of his-
tone H2AX to maintain S139 phosphorylation and IR-induced
foci formation, which is crucial for regulation of the DNA damage
response (Xiao et al., 2009). Rad53-associated Y99 phosphory-
lation of histone H3 is also critical for efficient ubiquitination
and degradation in the regulation of histone levels (Singh et al.,
2009). JAK2 phosphorylates Y41 of histone H3 and prevents
HP1a binding to chromatin (Dawson et al., 2009). WEE1
phosphorylates Y37 of histone H2B to suppress mRNA synthe-
sis of replication-dependent core histone genes (Mahajan
et al., 2012). Specifically, our study supports the concept that
H4-Y72 phosphorylation can regulate H4-K20 methylation to
affect histone-associated functions and raises interesting ques-
tions about the functional role of nuclear tyrosine kinases.
It is worthwhile to mention that both nEGFR and H4-K5 acet-
ylation have been shown to be involved in transcriptional regula-
tion (Fukuda et al., 2006; Huo et al., 2010; Peterson and Laniel,
2004;Wang andHung, 2009).We demonstrated that EGFR stim-
ulates H4-K5 acetylation, but this may not be regulated through
H4-Y72 phosphorylation, as the Y72F mutant still responded
to EGFR-enhanced H4-K5 acetylation (Figure S3A). Further
systematic study would be needed to address how EGFR upre-
gulates H4-K5 acetylation and whether this contributes to
nEGFR-mediated transcriptional regulation.
Although it is conceptually difficult to accept that an integral
membrane-embedded RTK can escape from the lipid bilayer
and enter the nucleus, recent studies have provided a compre-
hensive model of integral membrane-embedded EGFR traf-
ficking to the nucleus in a vesicle via coat-protein-complex-I-
mediated retrograde trafficking (Wang et al., 2010a, 2010c,
2012), which enables EGFR to stay in its membrane-embedded
form throughout the entire trafficking pathway from the cell
surface to the nucleus (Wang and Hung, 2012; Wang et al.,
2010b). The current study further provides a comprehensive
molecular mechanism governing the function of nEGFR, namely,
regulation of DNA synthesis and DNA repair through nEGFR-
mediated H4-Y72 phosphorylation to enhance recruitment of
SET8 and SUV4-20H for methylation at K20 of histone H4.
These findings, together with recent studies that have unrav-
eled a nuclear EGFR translocation trafficking pathway, provideDevecompelling evidence for more investigations into the potentially
important roles of a vast number of cell surface receptors in
the nucleus.
EXPERIMENTAL PROCEDURES
Duolink Proximity Ligation Assay
The in situ proximity ligation assay was performed using the Duolink II fluores-
cence kit (Olink Bioscience) according to the instructions. In brief, cells were
seeded on coverslips the day before the experiment. After treatment, cells
were fixed, permeabilized, blocked, and then incubated with primary anti-
bodies against EGFR and histone H4 at 4C overnight. After washing, the
oligonucleotide (Minus and Plus)-conjugated secondary antibodies were incu-
bated for another hour at 37C. Subsequently, cells were washed and incu-
bated with ligation solution for 30 min at 37C. Finally, the ligated nucleotide
circles were amplified by polymerase via rolling-circle amplification (RCA),
and the RCA products were visualized by hybridization with fluorescence-
labeled oligonucleotides. The visualized fluorescence spots represent the
clusters of protein-protein interactions.
In Vitro HMTase Assay
HMTases SET8 and SUV4-20H were immunoprecipitated from the nuclear
fraction ofMDA-MB-468 cells. The immunoprecipitated protein was incubated
with 1 mg of recombinant histone WT or Y72F mutant histone H4 protein as
substrate and S-adenosyl-L-methionine as the methyl donor in the reaction
buffer (50 mM Tris-HCl [pH 8.5], 100 mM NaCl, 10 mM dithiothreitol) at 30C
for 1 hr. The reaction mixture was then resolved on 15% SDS-PAGE. The
amount of methylated histone H4 was detected by western blotting with
specific antibodies.
Irradiation and DSB End-Joining Capacity Assay
To generate DNA damage, cells were irradiated with 100 kV photons (RX-650
Cabinet X-Radiator from Faxitron X-Ray) at a dose rate of 4 Gy/min. After
irradiation, cells were incubated at 37C for the indicated time and then har-
vested for further experiments. For the DSB end-joining capacity assay,
approximately 23 105 cells were seeded on each well of a 24-well plate. Cells
were transfected with 200 ng of Hind III-linearized or circular pGL3-CMV
plasmid, 10 ng of pRL-TK-Luc, 200 ng of myc-EGFR, and the indicated
amount of histone H4 expression plasmids for 48 hr to permit DSB repair
and expression of luciferase (Figure 6C, graph; see also the Figure 6D legend).
Luciferase activity was measured by the Dual-Luciferase Reporter System
(Promega). Cells were ruptured in the passive lysis buffer for 15min by shaking
at room temperature. Lysate (5 ml) was applied to dual luciferase assay re-
agent, and its luminescence was measured with a luminometer (Berthold).
The Renilla luciferase activity from pRL-TK-Luc was used for normalizing the
transfection efficiency. The DSB end-joining capacity was determined from
the ratio of the normalized luciferase activity from cells transfected with lin-
pGL3 and cir-pGL3 (Zhong et al., 2002).
Animal Studies
Tumor xenografts were established by orthotopic implantation of MDA-MB-
468 cells (1 3 107 cells in a 1:1 mixture of PBS and Matrigel [BD Biosciences]
in a total volume of 100 ml) into the mammary fat pads of 6- to 8-week-old
female severe combined immunodeficient mice. When the tumors were
palpable, mice were randomly separated into three groups. The mice were
administered PBS, scrambled peptide, or Y72 peptides (200 nmol per mouse)
by intratumoral injection every 3 days. The tumor size (in cubicmillimeters) was
measured every 3 days using the following formula (where V = volume): V =
0.5 3 length 3 squared diameter for 30 days. All animal experiments were
approved by the Institutional Review Board of Animal Experiments, China
Medical University Hospital.
Statistical Analysis
Data were analyzed by t test, and the IHC result from clinical tissueswas calcu-
lated by Pearson chi-square test (*p < 0.05, **p < 0.01).
A complete description of the materials and methods is provided in the
Supplemental Experimental Procedures.lopmental Cell 30, 224–237, July 28, 2014 ª2014 Elsevier Inc. 235
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